Abstract

MR imaging is a suitable instrument for the detection of incidental radiological findings in patients with early psychosis and guidance of subsequent treatment adjustments. We outline evidence showing the clinical utility of MR imaging to guide treatment selection by identifying radiological abnormalities and predicting clinical outcomes in early-stage psychosis. We argue that MR imaging is an indispensable screening tool to detect gross radiological abnormalities in early psychosis and implementation in routine clinical assessments is warranted. We highlight future key challenges and make pragmatic suggestions to exploit the potential of MR imaging to construct robust prognostic models for personalized early interventions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.